Skip to main content
Equibles
MDT logo

MDT · Medtronic plc · Metrics

Track MDT — free

Use MDT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MDT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$95.41 -1.18 (-1.22%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$122.04B
Shares
1.28B
Volume · Oct 23 6.01M Avg daily vol (3M) 16.33M

MDT metrics

120 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$95.41
Market cap
$122.04B

Price action

20 metrics
Price change (1W)
+0.7%
Price change (30D)
+7.6%
Price change (3M)
+14.7%
Price change (6M)
+14.5%
Price change (YTD)
-0.7%
Price change (1Y)
+1.3%
Trailing year
Price change (5Y)
-22.5%
52-week high
$105.35
52-week low
$73.75
Change from 52-week high
-9.4%
Change from 52-week low
+29.4%
Annualized volatility
24.7%
Annualized volatility (3M)
24.5%
Beta
0.2
RSI (14D)
59.8
Price vs SMA 50
+4.4%
Price vs SMA 200
+8.2%
Avg volume (3M)
16.33M
Relative volume
0.4
Average dollar volume
$1.47B

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
1.28B

Valuation

12 metrics
P / E (TTM)
23.5
Trailing earnings · reciprocal yield 4.3%
PEG ratio
0.6
EV / revenue
3.8×
reciprocal yield 26.6%
EV / EBITDA
14.5×
reciprocal yield 6.9%
EV / EBIT
20.8×
reciprocal yield 4.8%
P / sales
3.3×
reciprocal yield 30.8%
P / book
2.4
reciprocal yield 41.2%
FCF yield
5.0%
TTM · current market cap
Buyback yield
1.0%
P / FCF
19.9
reciprocal yield 5.0%
P / operating cash flow
15.2
reciprocal yield 6.6%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
26.2×
reciprocal yield 3.8%
P / E historical average (5Y)
26.7×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
3.9×
reciprocal yield 25.5%
EV / revenue historical average (5Y)
4.1×
reciprocal yield 24.5%
EV / EBIT historical average (3Y)
22.9×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
23.4×
reciprocal yield 4.3%
EV / EBITDA historical average (3Y)
15.8×
reciprocal yield 6.3%
EV / EBITDA historical average (5Y)
16.0×
reciprocal yield 6.2%

Dividends & buybacks

7 metrics
Dividend yield
3.0%
Trailing 12 months
Payout ratio
69.9%
Shareholder yield
4.0%
Dividend / share (TTM)
$2.86
Dividend growth YoY
+1.4%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-25

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-01

Profitability

9 metrics
Gross margin
65.0%
Operating margin
18.1%
Trailing 12 months
Net margin
13.9%
Gross profit (TTM)
$24.41B
Operating profit (TTM)
$6.79B
Net income (TTM)
$5.22B
Trailing 12 months
Diluted EPS (TTM)
$4.06
FCF margin
16.3%
Effective tax rate
20.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$29.16
Gross profit per diluted share (TTM)
$18.96
Operating profit per diluted share (TTM)
$5.27
EBITDA per diluted share (TTM)
$7.55
Net income per diluted share (TTM)
$4.06
Operating cash flow per diluted share (TTM)
$6.24
Free cash flow per diluted share (TTM)
$4.76
Capital expenditures per diluted share (TTM)
$1.48
R&D per diluted share (TTM)
$2.27
Stock compensation per diluted share (TTM)
$0.39
Book value per share
$38.64

Growth

11 metrics
Revenue growth YoY
+13.7%
Year over year
Net income growth YoY
+41.3%
Revenue (TTM)
$37.54B
Trailing 12 months
EPS growth YoY
+40.7%
Shares change YoY
-0.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.2%
Revenue CAGR (5Y)
+3.8%
EPS CAGR (3Y)
+9.8%
EPS CAGR (5Y)
+7.0%
FCF CAGR (3Y)
+5.8%
FCF CAGR (5Y)
+2.1%

Quality

14 metrics
Return on equity
10.4%
Return on assets
5.6%
Debt / equity
0.6
Current ratio
2.1
EBITDA (TTM)
$9.72B
Free cash flow (TTM)
$6.13B
Quick ratio
1.5
Interest coverage
9.4
Net debt / EBITDA
2.0
Return on invested capital
7.8%
Trailing 12 months
Net cash
−$19.33B
Latest balance sheet
Cash & equivalents
$1.69B
Total assets
$93.31B
Total debt
$28.15B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$8.04B
Capital expenditures (TTM)
$1.90B
R&D (TTM)
$2.92B
SG&A (TTM)
$12.18B
Stock compensation (TTM)
$496.00M
R&D / revenue
7.8%
Stock compensation / revenue
1.3%

Ownership (13F)

9 metrics
13F filers
2,150
13F filer change QoQ
-104
Institutional ownership
86.9%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
14.6%
Private-fund adviser ownership
13.6%
Active holders' share change QoQ
-2.0%
Holder tenure
18.5
Price vs estimated holder cost
-9.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.5%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.89M
Insider-sentiment score
56 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1613103 CUSIP G5960L103 13F (30d) 663 filings 646 filers Visit website Investor relations